• 中文
    • 登錄
    • 聯系我們
    ×
    目錄產品 » Anti-Eculizumab Antibody (13F5), mAb, Mouse
    Anti-Eculizumab Antibody (13F5), MAb, Mouse

    Standard curve of Eculizumab Sandwich ELISA. The Eculizumab Sandwich ELISA assay is developed by using Anti-Eculizumab Antibody (4F6), mAb, Mouse (GenScript, A02115-40) and Anti-Eculizumab Antibody (13F5), mAb, Mouse (GenScript, A02116-40) as the capture and detection antibodies, respectively.
    In this ELISA assay, Anti-Eculizumab Antibody (13F5), mAb, Mouse (GenScript, A02116-40) was labeled with Biotin.
    GenScript can provide customized conjugation services for this product per the customer's request.
    The sensitivity of detecting Eculizumab is up to 0.35 ng/ml.

    Anti-Eculizumab Antibody (13F5), MAb, Mouse

    Anti-Eculizumab Antibody (13F5) (GenScript, A02116-40) blocks Eculizumab binding with Human Complement protein ?C5.
    Coating antigen: Eculizumab 1 μg/ml.
    Complement protein ?C5 final concentration: 300 ng/ml.
    Anti-Eculizumab antibody dilutions start from 30 μg/ml.
    IC50= 1.053 μg/ml.

    Anti-Eculizumab Antibody (13F5), MAb, Mouse

    ELISA binding of Anti-Eculizumab Antibody (13F5), mAb, Mouse (GenScript, A02116-40) with Eculizumab. While the antibody does not recognize the human IgG (data not shown).
    Coating antigen: Eculizumab, 1 μg/ml.
    Anti-Eculizumab Antibody (13F5), mAb, Mouse (GenScript, A02116-40) dilution start from 1,000 ng/ml.
    EC50= 25.09 ng/ml.

    Anti-Eculizumab Antibody (13F5), mAb, Mouse

    This product is specific for Eculizumab
    A02116
    ¥990

    聯系我們
    Specificity This product is specific for Eculizumab
    Host Species Mouse
    Immunogen Eculizumab
    Conjugate Unconjugated

    Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
    Application Recommended Usage
    ELISA 0.005-1 μg/ml
    Competitive ELISA 10-50 μg/ml

    Form Lyophilized
    Storage Buffer This product is lyophilized with PBS, pH 7.2, containing 0.02% sodium azide.
    Reconstitution Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/ml.
    Storage Instructions The lyophilized product remains stable up to 1 year at -20 °C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid repeated freezing and thawing cycles.
    Purification Protein A affinity column
    Isotype Mouse IgG1,κ
    Clonality Monoclonal
    Clone ID 13F5
    Note GenScript can customize this product per customer's request including product size, buffer components, etc.

    • Anti-Eculizumab Antibody (13F5), MAb, Mouse
    • Anti-Eculizumab Antibody (13F5), MAb, Mouse

      Standard curve of Eculizumab Sandwich ELISA. The Eculizumab Sandwich ELISA assay is developed by using Anti-Eculizumab Antibody (4F6), mAb, Mouse (GenScript, A02115-40) and Anti-Eculizumab Antibody (13F5), mAb, Mouse (GenScript, A02116-40) as the capture and detection antibodies, respectively.
      In this ELISA assay, Anti-Eculizumab Antibody (13F5), mAb, Mouse (GenScript, A02116-40) was labeled with Biotin.
      GenScript can provide customized conjugation services for this product per the customer's request.
      The sensitivity of detecting Eculizumab is up to 0.35 ng/ml.

    • Anti-Eculizumab Antibody (13F5), MAb, Mouse
    • Anti-Eculizumab Antibody (13F5), MAb, Mouse

      Anti-Eculizumab Antibody (13F5) (GenScript, A02116-40) blocks Eculizumab binding with Human Complement protein ?C5.
      Coating antigen: Eculizumab 1 μg/ml.
      Complement protein ?C5 final concentration: 300 ng/ml.
      Anti-Eculizumab antibody dilutions start from 30 μg/ml.
      IC50= 1.053 μg/ml.

    • Anti-Eculizumab Antibody (13F5), MAb, Mouse
    • Anti-Eculizumab Antibody (13F5), MAb, Mouse

      ELISA binding of Anti-Eculizumab Antibody (13F5), mAb, Mouse (GenScript, A02116-40) with Eculizumab. While the antibody does not recognize the human IgG (data not shown).
      Coating antigen: Eculizumab, 1 μg/ml.
      Anti-Eculizumab Antibody (13F5), mAb, Mouse (GenScript, A02116-40) dilution start from 1,000 ng/ml.
      EC50= 25.09 ng/ml.


    Target Background Eculizumab with trade name Soliris, is an FDA-approved drug to treat paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica. Eculizumab is a recombinant humanized monoclonal antibody against the complement protein C5. Eculizumab specifically binds to the terminal complement component 5, or C5. Binding to this protein prevents the activation of a complement terminal complex, which is used to treat a number of autoimmune conditions.Anti-Eculizumab Antibody (13F5), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Eculizumab.
    Synonyms Mouse monoclonal to Eculizumab/Soliris

    For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.


    国产小受呻吟cv视频在线观看